Administrative Core

行政核心将协调IPCAVD计划的科学和行政活动， 确保项目和核心一起运作良好。特别是，它将负责管理 该计划的财务管理，计划管理，并通过协调项目和核心， 科学会议和交流，以及确保完全遵守财务和监管规定。一 核心小组的主要活动将是监控IPCAVD相对于里程碑的进展情况，并对其进行测量 根据现有资金取得进展，以确保资源得到有效利用。核心会协调 外部咨询委员会（EAC）将审查IPCAVD项目和核心的进展情况，以及 根据DAIDS计划团队的意见，为计划的方向提供指导。核心员工是 一个经验丰富的综合管理团队，这将使立即启动和快速 中求进工作总这种团队合作将加速实现该计划的目标，从而最大限度地 这是一个对人类HIV-1疫苗研究产生积极影响的机会。行政的具体目标 核心如下。 目标1.对项目进行全面的IPCAVD管理、协调和监督。 目标2.确保及时的财务会计和报告。 目标3：确保遵守所有机构、州和联邦研究和CGMP指南。 目标4。制定和实施IPCAVD的沟通、出版和数据共享计划。 目标5。为所有数据分析提供统计支持。

The Administrative Core will coordinate the scientific and administrative activities of this IPCAVD Program, ensuring that the Projects and Cores function well together. In particular, it will be responsible for managing the program's financial management, program management, and coordinating Projects and Cores through scientific meetings and communications, as well as ensuring full financial and regulatory compliance. A primary activity of the Core will be monitoring IPCAVD progress relative to milestones and measuring this progress against available funding to ensure resources are used efficiently. The Core will coordinate the effort of an External Advisory Committee (EAC) that will review the progress of IPCAVD Projects and Cores, and with input from the DAIDS Program Team, provide guidance for the Program's direction. Core staff are part of a highly experienced and integrated management team, which will enable immediate start-up and rapid progress. This teamwork will accelerate advancement toward the Program's goals, thus maximizing the opportunities to positively impact HIV-1 vaccine research in humans. The Specific Aims of the Administrative Core are as follows. Aim 1. Provide overall IPCAVD management, coordination and supervision of the Program. Aim 2. Ensure timely financial accounting and reporting. Aim 3. Ensure compliance with all institutional, state, and federal research and CGMP guidelines. Aim 4. Develop and implement IPCAVD communication, publication, and data sharing plans. Aim 5. Provide statistical support for all data analyses.